Finance

Lists
2M6:ETR
Medtronic PLC
€72,50
+0,55%
(+0,40) 1D
23 Jul., 17:35:56 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 2M6...
Open
€72,32
High
€72,66
Low
€71,40
Mkt. cap
104,98 mjd
Avg. vol.
1,76 k
Volume
1,19 k
52-wk high
€91,50
52-wk low
€62,86
No. of employees
95 k
Open
€72,32
High
€72,66
Low
€71,40
Mkt. cap
104,98 mjd
Avg. vol.
1,76 k
Volume
1,19 k
52-wk high
€91,50
52-wk low
€62,86
No. of employees
95 k
News stories
From sources across the web
Profile
Medtronic plc is an American-Irish medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue. The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter-defibrillator, and remote patient monitoring systems. They also created miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
About Medtronic PLC
CEOGeoffrey S. Martha
Employees95 k
Founded1949
Headquarters-
SectorMedical device
Last report
03 Jun. 2026
Fiscal period
Q4 2026
EPS / Est. (USD)
USD 1,55 / USD 1,54
+0,56%beat
Revenue / Est. (USD)
9,81 mjd / 9,61 mjd
+2,02%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul. 2025
Okt. 2025
Jan. 2026
Apr. 2026
Revenue
8,58 mjd
8,96 mjd
9,02 mjd
9,81 mjd
Cost of goods sold
2,98 mjd
3,06 mjd
3,17 mjd
3,40 mjd
Cost of revenue
2,98 mjd
3,06 mjd
3,17 mjd
3,40 mjd
Research and development expenses
726,00 m
754,00 m
722,00 m
671,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,78 mjd
2,94 mjd
2,93 mjd
3,04 mjd
Operating expense
3,99 mjd
4,08 mjd
4,04 mjd
4,25 mjd
Total operating expenses
6,98 mjd
7,14 mjd
7,21 mjd
7,64 mjd
Operating income
1,60 mjd
1,82 mjd
1,80 mjd
2,16 mjd
Other non operating income
68,00 m
3,00 m
13,00 m
154,00 m
EBT including unusual items
1,30 mjd
1,60 mjd
1,40 mjd
1,84 mjd
EBT excluding unusual items
1,62 mjd
1,68 mjd
1,66 mjd
2,16 mjd
Income tax expense
255,00 m
215,00 m
254,00 m
575,00 m
Effective tax rate
19,59%
13,47%
18,10%
31,34%
Other operating expenses
72,00 m
-29,00 m
-79,00 m
126,00 m
Net income
1,04 mjd
1,37 mjd
1,14 mjd
1,24 mjd
Net profit margin
12,12%
15,33%
12,68%
12,68%
Earnings per share
1,26
1,36
1,36
1,55
Interest and investment income
120,00 m
89,00 m
102,00 m
73,00 m
Interest expense
-176,00 m
-181,00 m
-181,00 m
-176,00 m
Net interest expenses
-56,00 m
-92,00 m
-79,00 m
-103,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
2,31 mjd
2,52 mjd
2,52 mjd
2,88 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more